These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28299666)

  • 41. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
    Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
    Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RUNX3 functions as an oncogene in ovarian cancer.
    Lee CW; Chuang LS; Kimura S; Lai SK; Ong CW; Yan B; Salto-Tellez M; Choolani M; Ito Y
    Gynecol Oncol; 2011 Aug; 122(2):410-7. PubMed ID: 21612813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogenic role of RUNX3 in head and neck cancer.
    Kudo Y; Tsunematsu T; Takata T
    J Cell Biochem; 2011 Feb; 112(2):387-93. PubMed ID: 21268058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation.
    Soung do Y; Dong Y; Wang Y; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
    J Bone Miner Res; 2007 Aug; 22(8):1260-70. PubMed ID: 17488194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
    Han YX; Liang DY
    Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
    Fukamachi H; Ito K; Ito Y
    Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
    Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
    Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The oncogenic roles of p53 mutants in mouse models.
    Lozano G
    Curr Opin Genet Dev; 2007 Feb; 17(1):66-70. PubMed ID: 17208429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
    Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
    EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Runx3 expression during mouse tongue and palate development.
    Yamamoto H; Ito K; Kawai M; Murakami Y; Bessho K; Ito Y
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Jul; 288(7):695-9. PubMed ID: 16761282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
    Ito Y
    Adv Cancer Res; 2008; 99():33-76. PubMed ID: 18037406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.
    Tonomoto Y; Tachibana M; Dhar DK; Onoda T; Hata K; Ohnuma H; Tanaka T; Nagasue N
    Oncology; 2007; 73(5-6):346-56. PubMed ID: 18500170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
    Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
    Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of RUNX Family Transcription Factors in DNA Damage Response.
    Samarakkody AS; Shin NY; Cantor AB
    Mol Cells; 2020 Feb; 43(2):99-106. PubMed ID: 32024352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functions.
    Kumar A; Singhal M; Chopra C; Srinivasan S; Surabhi RP; Kanumuri R; Tentu S; Jagadeeshan S; Sundaram S; Ramanathan K; Shankar Pitani R; Muthuswamy B; Abhijit S; Nair AS; Venkatraman G; Rayala SK
    Oncogene; 2016 Sep; 35(37):4857-65. PubMed ID: 26898755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53-induced apoptosis as a safeguard against cancer.
    Asker C; Wiman KG; Selivanova G
    Biochem Biophys Res Commun; 1999 Nov; 265(1):1-6. PubMed ID: 10548481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
    Mallette FA; Gaumont-Leclerc MF; Ferbeyre G
    Genes Dev; 2007 Jan; 21(1):43-8. PubMed ID: 17210786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.